Castellum, Inc.'s Q2 shows strong revenue growth, rising profitability, and a healthier balance sheet. Click for my CTM ...

Global Dynamic Dividend Fund underperformed its benchmark over the 3-month period ending 31 July 2025 due to stock selection ...

Regencell remains wildly overvalued despite an 80% stock drop, with no revenue, assets, or business activity to justify its ...

Safran is considering the sale of a large part of its aircraft interiors business, which could be worth as much as €1.5B, the ...

The Fund gained (gross of fees) but underperformed the Russell 2000 Index. Sector wise, healthcare and materials were the ...

GitLab stock is now undervalued after its Q3 guidance miss. Discover why it's rated a "Strong Buy" and how its growth ...

REITs are attractive now due to low inflation, expected rate cuts, and technical indicators suggesting a bullish trend with ...

J.Jill is working to revamp the assortment to expand the consumer base and gain back customers. Click here to read an ...

Despite past clinical successes, MacroGenics has sold or out-licensed its three FDA-approved therapies for cash, milestones, ...

Supreme Court ruling on Trump tariffs could spark major market shifts—expect stock declines, rising rates, and record gold ...

Guidewire Software (GWRE) jumps 15% after Q4 results and a strong FY 2026 outlook. Discover key growth drivers and analyst ...

Shares of EHang ( NASDAQ: EH) perked up Friday morning after the company announced a partnership with China Road and Bridge ...